JP2024515459A5 - - Google Patents
Info
- Publication number
- JP2024515459A5 JP2024515459A5 JP2023558203A JP2023558203A JP2024515459A5 JP 2024515459 A5 JP2024515459 A5 JP 2024515459A5 JP 2023558203 A JP2023558203 A JP 2023558203A JP 2023558203 A JP2023558203 A JP 2023558203A JP 2024515459 A5 JP2024515459 A5 JP 2024515459A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- approximately
- composition according
- identity
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163180646P | 2021-04-27 | 2021-04-27 | |
| US63/180,646 | 2021-04-27 | ||
| PCT/US2022/071937 WO2022232790A1 (en) | 2021-04-27 | 2022-04-26 | Methods of treating ocular diseases using aav2 variants encoding aflibercept |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515459A JP2024515459A (ja) | 2024-04-10 |
| JP2024515459A5 true JP2024515459A5 (enExample) | 2025-04-28 |
Family
ID=81984711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558203A Pending JP2024515459A (ja) | 2021-04-27 | 2022-04-26 | アフリベルセプトをコードするａａｖ２バリアントを使用する眼疾患の治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240197915A1 (enExample) |
| EP (1) | EP4329721A1 (enExample) |
| JP (1) | JP2024515459A (enExample) |
| KR (1) | KR20240005764A (enExample) |
| CN (1) | CN117222400A (enExample) |
| BR (1) | BR112023019056A2 (enExample) |
| CA (1) | CA3215855A1 (enExample) |
| MX (1) | MX2023012410A (enExample) |
| WO (1) | WO2022232790A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS67656B1 (sr) | 2018-05-10 | 2026-02-27 | Regeneron Pharma | Formulacije koje sadrže visoke koncentracije fuzionog proteina vegf receptora |
| PE20240329A1 (es) | 2019-06-05 | 2024-02-27 | Regeneron Pharma | Dispositivos y metodos para administracion de dosis de precision |
| US12649031B2 (en) | 2021-09-08 | 2026-06-09 | Regeneron Pharmaceuticals, Inc. | Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| KR20260005446A (ko) | 2024-07-03 | 2026-01-12 | 김성훈 | 김치 제조 장치 |
| KR20260006393A (ko) | 2024-07-04 | 2026-01-13 | 김성훈 | 가정용 김치 제조 장치 |
| TW202607144A (zh) * | 2024-07-16 | 2026-02-16 | 美商愛德維仁生物科技公司 | 使用編碼阿柏西普（ａｆｌｉｂｅｒｃｅｐｔ）之ａａｖ２變異體治療眼部新生血管性疾病的方法 |
| WO2026160680A1 (ko) * | 2025-01-24 | 2026-07-30 | 연세대학교 산학협력단 | 망막 세포 표적화 아데노-관련 바이러스 변이체 adn 및 그의 용도 |
| WO2026160681A1 (ko) * | 2025-01-24 | 2026-07-30 | 연세대학교 산학협력단 | 망막 세포 표적화 아데노-관련 바이러스 변이체 kap 및 그의 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3693025T3 (da) * | 2011-04-22 | 2022-01-10 | Univ California | Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf |
| ES2908467T3 (es) * | 2016-04-29 | 2022-04-29 | Adverum Biotechnologies Inc | Evasión de anticuerpos neutralizantes por un virus adenoasociado recombinante |
| CN117531025A (zh) * | 2016-06-16 | 2024-02-09 | 阿德夫拉姆生物技术股份有限公司 | 使用aav2变体和阿柏西普治疗amd |
| KR102616820B1 (ko) | 2017-03-17 | 2023-12-21 | 애드베룸 바이오테크놀로지스, 인코포레이티드 | 향상된 유전자 발현을 위한 조성물 및 방법 |
| TW201904610A (zh) * | 2017-06-14 | 2019-02-01 | 德商拜耳製藥公司 | 用於治療新生血管型青光眼之非抗體vegf拮抗劑 |
| WO2020180951A1 (en) * | 2019-03-04 | 2020-09-10 | Adverum Biotechnologies, Inc. | Sequential intravitreal administration of aav gene therapy to contralateral eyes |
| JP7893739B2 (ja) | 2019-09-11 | 2026-07-23 | アドヴェラム バイオテクノロジーズ， インコーポレイテッド | アフリベルセプトをコードするａａｖ２バリアントを使用する眼内血管新生疾患を処置する方法 |
| KR20260017004A (ko) * | 2019-09-11 | 2026-02-04 | 애드베룸 바이오테크놀로지스, 인코포레이티드 | 아플리베르셉트를 코딩하는 aav2 변이체를 사용하여 안구 신생혈관 질환을 치료하는 방법 |
| CN114375195A (zh) | 2019-09-11 | 2022-04-19 | 阿德夫拉姆生物技术股份有限公司 | 使用编码阿柏西普的aav2变体治疗眼新血管疾病的方法 |
-
2022
- 2022-04-26 CN CN202280030462.0A patent/CN117222400A/zh active Pending
- 2022-04-26 WO PCT/US2022/071937 patent/WO2022232790A1/en not_active Ceased
- 2022-04-26 CA CA3215855A patent/CA3215855A1/en active Pending
- 2022-04-26 BR BR112023019056A patent/BR112023019056A2/pt unknown
- 2022-04-26 EP EP22729004.6A patent/EP4329721A1/en active Pending
- 2022-04-26 US US18/554,965 patent/US20240197915A1/en active Pending
- 2022-04-26 JP JP2023558203A patent/JP2024515459A/ja active Pending
- 2022-04-26 KR KR1020237040171A patent/KR20240005764A/ko active Pending
- 2022-04-26 MX MX2023012410A patent/MX2023012410A/es unknown